August 6, 2024 01:21 PM EDTUpdated August 7, 08:57 AM
Pharma
Law

No­vo Nordisk goes af­ter more com­pounders, ex­pand­ing GLP-1 law­suit cam­paign

Nicole DeFeudis

Editor

No­vo Nordisk is turn­ing up the heat on com­pound­ing phar­ma­cies mak­ing ver­sions of its block­buster.

Late last week, the com­pa­ny filed 11 new law­suits against …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Stem cell start­up spun out of George Church’s lab rais­es $75M

Here's what to­day's Fed rate cut means for biotech, phar­ma and ven­ture cap­i­tal

FDA re­jects Van­da’s treat­ment for di­ges­tion con­di­tion, com­pa­ny re­bukes agen­cy's ac­tions

Up­stream Bio files for IPO in sign of life for biotech pub­lic of­fer­ings

Edge­wise’s stock surges as heart drug pass­es ear­ly safe­ty test

sponsored

Break­ing down si­los with a new quan­ti­ta­tive ap­proach to drug de­vel­op­ment

A service from the Financial Times